Skip to main content
. Author manuscript; available in PMC: 2011 Jul 29.
Published in final edited form as: J Hepatol. 2009 Feb 14;50(4):705–711. doi: 10.1016/j.jhep.2008.12.021

Fig. 3.

Fig. 3

Comparison of SOCS3 expression in patients with HCV–HIV coinfection. (A) Non-responders (n = 15) exhibit higher pretreatment hepatic SOCS3 expression than responders (n = 10) in patients with HCV/HIV coinfection. (B) AA (n = 9) have higher pretreatment SOCS3 expression than non-AA (= 16). Data are presented as means ± SEM. *p < 0.05. [This figure appears in colour on the web.]